Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome |
| |
Authors: | Neeti Sharma Avinash M. Mali Sharmila A. Bapat |
| |
Affiliation: | (1) Division of Medical Genetics, San Paolo School of Medicine, University of Milan, Italy;(2) I Clinica Pediatrica, Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy;(3) Department of Biology and Genetics, Medical Faculty, University of Milan, Milan, Italy;(4) Neuropsichiatria Infantile, Spedali Civili, Brescia, Italy;(5) Laboratory of Molecular Genetics, G. Gaslini Institute, Genova, Italy;(6) Department of Paediatrics, Genetics Unit – Children's Hospital A. Meyer, Florence, Italy;(7) Institute of Medical Genetics, Catholic University, Rome, Italy;(8) Servizio di Genetica Medica, Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy;(9) Department of Human Genetics of Galliera Hospital, , Genoa, Italy |
| |
Abstract: | Rubinstein-Taybi syndrome (RSTS), a developmental disorder comprising abnormalities that include mental retardation, an unusual facial appearance, broad thumbs and big toes is frequently associated with molecular lesions in the CREB-binding protein gene, CREBBP. The objective of the present study was to identify and analyse CREBBP mutations in Indian RSTS patients on which there are no data. Direct sequencing of CREBBP performed in 13 RSTS patients identified the three zinc fingers (CH1, CH2, CH3) and HAT domain as mutational hotspots in which ten novel pathogenic mutations were localized. Functional analysis revealed that three of these mutations affecting amino acids Glu1459, Leu1668 and Glu1724 were critical for histone acetyltransferase activity. Twenty-eight novel CREBBP single-nucleotide polymorphisms (SNPs) were also identified in the Indian population. Linkage disequilibrium studies revealed associations between (i) SNP (rs129974/c.3836-206G>C) and mutation (p.Asp1340Ala); (ii) (rs130002) with mutation (p.Asn435Lys) and (iii) SNPs rs129974, rs130002 and SNP (c.3836-206G>C) signifying a disease affection status. In conclusion, the present study reports the highest detection rate of CREBBP mutations (76.9%) in RSTS patients to date, of which ten are predicted to be pathogenic and three critical for histone acetyltransferase activity. Moreover, identification of the association of CREBBP polymorphisms with disease susceptibility could be an important risk factor for the pathogenesis of RSTS. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|